The Haematology and Stem Cell Transplant Unit is a structure of excellence for the diagnosis and treatment of neoplastic (myelomas, lymphomas and leukaemias), and non-neoplastic haematologic diseases (anaemia , acquired haemorrhagic disorders, thrombocytopenia, hereditary and/or acquired thrombophilia , miscarriages related to haematologic causes, etc.). Close collaboration with national and international cooperative groups allows the Unit to provide patients with top-quality clinical care. The Unit is an active member of several national (GIMEMA, FIL) and international (IELSG) cooperative groups; it applies protocols proposed by such cooperative groups for chemotherapy, cell therapy, radiotherapy and biological therapies, which stimulate the immune system to recognise and destroy neoplastic cells. The Unit is accredited by JACIE (Joint Accreditation Committee – ISCT & EBMT), an organisation that guarantees international quality and safety standards for stem cell transplant procedures. Because blood disorders can affect other organs and areas of the body, the haematologists of the unit collaborate with experts in nearly every specialty such as: internal medicine, radiology, oncology, radiation oncology, pathology and others. The Unit is a member of the Rome Transplant Network (RTN) a network of six Roma blood centres of excellence performing stem cell transplants according to common protocols, certified by international bodies, the National Transplant Centres (CNT, Centro Nazionale Trapianti) and the National Blood Centre (CNS, Centro Nazionale Sangue) and accredited by JACIE.
All services are provided by arrangement with the SSN and privately, both on an outpatient and a day-hospital basis. However, treatment of acute leukemias, aggressive lymphomas and transplant procedures are carried out only in ordinary hospitalisation.